参考文献/References:
［1］ BAUER S，GROH V，WU J，et al.Activation on of NK cells and T cells by NKG2D，a receptor for stress-inducible MICA［J］.Science，1999，285（5428）：727-729.
［2］ RCKRICH T，STEINLE A.Attenuated natural killer （NK） cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif （HemITAM） with impaired Syk kinase recruitment capacity［J］.J Biol Chem，2013，288（24）：17725-17733.
［3］ RUCK T，BITTNER S，AFZALI A M，et al.The NKG2D-IL-15 signaling pathway contributes to T cell mediated pathology in inflam-matory myopathies［J］.Oncotarget，2015，6（41）：43230-43243.
［4］ PARK Y P，CHOI S C，KIESLER P，et al.Complex regulation of human NKG2D-DAP10 cell surface expression：opposing roles of theγc cytokines and TGF-β1［J］.Blood，2011，118（11）：3019-3027.
［5］ GARRITY D，CALL M E，FENG J，et al.Theactivating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure［J］.Proc Natl Acad Sci USA，2005，102（24）：7641-7646.
［6］ ZHANG C，ZHANG J，NIU J，et al.Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of N-KG2D［J］.Hum Immunol，2008，69（8）：490-500.
［7］ RUCK T，BITTNER S，AFZALI A M，et al.The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies［J］.Oncotarget，2015，6（41）：43230-43243.
［8］ SONG H，KIM Y，PARK G，et al.Transforming growth factor-β1 regulates human renal proximal tubular epithelial cell susceptibility to natural killer cells via modulation of the NKG2D ligands［J］.Int J Mol Med，2015，36（4）：1180-1188.
［9］ 赵楠，赵明峰，RAJBNANDA S，等.内源性表达白细胞介素21的CIK细胞的抗白细胞作用和机制［J］.中华医学杂志，2013，93（4）：293-299.
［10］ ZHANG C，ZHANG J，SUN R，et al.Opposing effect of IFN-γ and IFN-α on expression of NKG2D receptors：negative regulation of IFN-γ on NK cells［J］.Int Immunopharmacol，2005，5（6）：1057-1067.
［11］ GROH V，BAHRAM S，BAUER S，et al.Cell stressregulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium［J］.Proc Natl Acad Sci USA，1996，93（22）：12445-12450.
［12］ FRIESE M A，PLATTEN M，LUTZ S Z，et al.MICA/NKG2D-mediated immunogene therapy of experimental gliomas［J］.Cancer Res，2003，63（24）：8996-9006
［13］ WU J Y，ERNSTOFF M S，HILL J M，et al.Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma［J］.Cytotherapy，2006，8（2）：141-148.
［14］ CARLSTEN M，BJRKSTROM N K，NORELL H，et al.DNAX accessory molecule-1 mdiated recognition of freshly isolated ovarian carcinoma by resting natural killer cells［J］.Cancer Res，2007，67（3）：1317-1325.
［15］ CODO P，WELLER M，MEISTER G，et al.MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape［J］.Oncotarget，2014，5（17）：7651-7662.
［16］ DAYANC B E，BANSAL S，GURE A O，et al.Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA［J］.Int J Hyperthermia，2013，29（5）：480-490.
［17］ DE KRUIJF E M，SAJET A，VAN NES J G，et al.NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients：an observational study［J］.BMC Cancer，2012，12（8）：24-36.
［18］ KAMIMURA H，YAMAGIWA S，TSUCHIYA A，et al.Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence［J］.J Hepatol，2012，56（2）：381-388.
［19］ OKITA R，MOUGIAKAKOS D，ANDO T，et al.HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines［J］.J Immunol，2012，188（5）：2136-2145.
［20］ HAGEMANN-JENSEN M，UHLENBROCK F，KE-HLET S，et al.The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D［J］.Biol Chem，2014，289（45）：31576-31590.
［21］ SUVOROVA II，KOZHUKHAROVA I V，NIKOL′SKI N N,et al.ATM/ATR signaling pathway activation in human embryonic stem cells after DNA damage［J］.Tsitologiia，2013，55（12）：841-851.
［22］ TEXTOR S，FIEGLER N，ARNOLD A，et al.Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2［J］.Cancer Res，2011，71（18）：5998-6009.
［23］ JIE H B，SCHULER P J，LEE S C et al.CTLA-4+regulatory T cells increased in cetuximab-treated head and neck cancer patients suppress NK cell cytotoxicity and correlate with poor prognosis［J］.Cancer Res，2015，75（11）：2200-2210.
［24］ TSUKERMAN P，STERN-GINOSSAR N，GUR C，et al.MiRNA-10b downregulates the stress-induced cell surface molecule MICB，a critical ligand for cancer cell recognition by natural killer cells［J］.Cancer Res，2012，72（21）：5463-5472.
［25］ SMYTH M J，SWANN J，KELLY J M，et al.NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer［J］.J Exp Med，2004，200（10）：1325-1335.
［26］ PORTER D L，LEVINE B L，KALOS M，et al.Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia［J］.N Engl J Med，2011，365（8）：725-733.
［27］ BARBER A，SENTMAN C L.NKG2D receptor regulates human effector T-cell cytokine production［J］.Blood，2011，117（24）：6571-6581.
［28］ VANSEGGELEN H，HAMMILL J A，DVORKIN-GHEVA A，et al.T cells engineered with chimeric antigen receptors targeting NKG2D ligands display lethal toxicity in mice［J］.Mol Ther，2015，23（10）：1600-1610.
［29］ LYNN R C，POWELL D J JR.Strain-dependent lethal toxicity in NKG2D ligand-targeted CAR T-cell therapy［J］.Mol Ther，2015，23（10）：1559-1561.
［30］ ZHANG T，BARBER A，SENTMAN C L.Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor［J］.Cancer Res，2006，66（11）：5927-5933.
［31］ KELLNER C，HALLACK D，GLORIUS P，et al.Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity［J］.Leukemia，2012，26（4）：830-834.
相似文献/References:
[1]王国征,吴远彬,郭坤元,等.CD34CD38KG1a白血病干细胞对同种异体自然杀伤细胞的抵抗作用及其机制[J].新乡医学院学报,2019,36(9):828.[doi:10.7683/xxyxyxb.2019.09.006]
WANG Guo-zheng,WU Yuan-bin,GUO Kun-yuan,et al.Resistance of CD34CD38KG1a leukemic stem cells to allogeneic nature killer cells and its mechanism[J].Journal of Xinxiang Medical University,2019,36(1):828.[doi:10.7683/xxyxyxb.2019.09.006]